Citation: F. May et al., The ability of the American Joint Committee On Cancer Staging system to predict progression-free survival after radical prostatectomy, BJU INT, 88(7), 2001, pp. 702-707
Authors:
May, F
Treumann, T
Dettmar, P
Hartung, R
Breul, J
Citation: F. May et al., Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer, BJU INT, 87(1), 2001, pp. 66-69
Authors:
Paul, R
Alschibaja, M
von Randenborgh, H
Hartung, R
Breul, J
Citation: R. Paul et al., Neoadjuvant hormonal therapy for localized prostate cancer prior to curative radical prostatectomy - Advantage or disadvantage?, AKT UROL, 32(4), 2001, pp. 165-172
Authors:
van Randenborgh, H
Breul, J
Leyh, H
Hartung, R
Citation: H. Van Randenborgh et al., Urinary continence and positive margins in radical retropubic prostatectomy after preparation of an intraprostatic urethral stump, AKT UROL, 32(2), 2001, pp. 84-86
Authors:
Paul, R
Bottermann, P
Breul, J
Hartung, R
Citation: R. Paul et al., Isoenzymes of alkaline phosphatase - Useful parameters for identification of bone metastasis in prostatic carcinoma?, ONKOLOGIE, 23(1), 2000, pp. 42-46
Authors:
Hofer, C
Hartung, R
Gobel, R
Deering, P
Lehmer, A
Breul, J
Citation: C. Hofer et al., New ultradeformable drug carriers for potential transdermal application ofinterleukin-2 and interferon-alpha: Theoretic add practical aspects, WORLD J SUR, 24(10), 2000, pp. 1187-1189
Citation: R. Paul et J. Breul, Antiandrogen withdrawal syndrome associated with prostate cancer therapies- Incidence and clinical significance, DRUG SAFETY, 23(5), 2000, pp. 381-390
Authors:
Hofer, C
Sauerstein, P
Wolter, C
Scholz, M
Hartung, R
Breul, J
Citation: C. Hofer et al., Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist, UROL INTERN, 64(1), 2000, pp. 18-23
Authors:
Hofer, C
Laubenbacher, C
Block, T
Breul, J
Hartung, R
Schwaiger, M
Citation: C. Hofer et al., Fluorine-18-fluorodeoxyglucose positron emission tomography is useless forthe detection of local recurrence after radical prostatectomy, EUR UROL, 36(1), 1999, pp. 31-35
Authors:
Hofer, C
Gobel, R
Deering, P
Lehmer, A
Breul, J
Citation: C. Hofer et al., Formulation of interleukin-2 and interferon-alpha containing ultradeformable carriers for potential transdermal application, ANTICANC R, 19(2C), 1999, pp. 1505-1507